A phase II, randomised, double-blind, placebo controlled, multicentre study to evaluate the efficacy, safety and toleration of Sildenafil administrered for 12 weeks to women with sexual disfunction associated with female sexual disorders.Pfizer; durata: agosto 1997-aprile 1998